Search results
Results From The WOW.Com Content Network
Prolonged use of stimulant laxatives can create drug dependence by damaging the colon's haustral folds, making users less able to move feces through their colon on their own. A study of patients with chronic constipation found that 28% of chronic stimulant laxative users lost haustral folds over the course of one year, while none of the control ...
Long-term use is sometimes described as use not shorter than three months. [2] Benzodiazepines are generally effective when used therapeutically in the short term, [3] but even then the risk of dependency can be significantly high. There are significant physical, mental and social risks associated with the long-term use of benzodiazepines. [3]
Alpidem (Ananxyl) 1995. Worldwide. Not approved in the US, withdrawn in France in 1994 [ 4] and the rest of the market in 1995 because of rare but serious hepatotoxicity. [ 3][ 5] Alosetron (Lotronex) 2000. US. Serious gastrointestinal adverse events; ischemic colitis; severe constipation. [ 2] Reintroduced 2002 with restricted indication and ...
Loperamide. Loperamide, sold under the brand name Imodium, among others, [ 1] is a medication of the opioid receptor agonist class used to decrease the frequency of diarrhea. [ 5][ 4] It is often used for this purpose in irritable bowel syndrome, inflammatory bowel disease, short bowel syndrome [ 4] Crohn's disease and ulcerative colitis. [ 5]
The use of weight-loss products happens "at high levels in adolescents, especially girls," and can have long-term health consequences, they conclude. The meta-analysis included 90 studies with ...
Macrogol 4000, pharmaceutical quality. Macrogol 3350, often in combination with electrolytes, is used for short-term relief of constipation as well as for long-term use in constipation of various causes, including in multiple sclerosis and Parkinson's disease patients (an often-overlooked non-motor symptom) as well as constipation caused by pharmaceutical drugs such as opioids and ...
The majority of insurance plans, including Medicare, don’t cover Wegovy or any other anti-obesity drugs. The list price of Ozempic is $892 per injector pen, which usually contains a month’s ...
August 15, 2024 at 11:08 AM. Scott Olson/Getty Images. Medicare’s new power to negotiate drug prices will lead to an estimated $6 billion in savings for the federal government and a $1.5 billion ...